Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aadi Bioscience Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AADI
Nasdaq
2834
https://aadibio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aadi Bioscience Inc
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
- Nov 8th, 2023 1:00 pm
Aadi Bioscience to Participate in Jefferies London Healthcare Conference
- Nov 6th, 2023 9:05 pm
Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update
- Nov 1st, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting
- Oct 19th, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Oct 12th, 2023 8:05 pm
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium
- Oct 5th, 2023 8:05 pm
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
- Oct 3rd, 2023 8:05 pm
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
- Oct 2nd, 2023 12:00 pm
Aadi Bioscience to Participate at Upcoming Investor Conferences
- Sep 5th, 2023 12:00 pm
Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update
- Aug 9th, 2023 12:00 pm
Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update
- Aug 2nd, 2023 12:00 pm
Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- May 25th, 2023 9:30 pm
Aadi Bioscience to Participate in Upcoming Investor Events
- May 23rd, 2023 12:00 pm
Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial
- May 10th, 2023 12:00 pm
Aadi Bioscience to Report First Quarter 2023 Results and Operational Update
- May 3rd, 2023 12:00 pm
Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 26th, 2023 8:05 pm
Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
- Apr 14th, 2023 5:00 pm
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023
- Apr 6th, 2023 8:30 pm
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update
- Mar 28th, 2023 12:00 pm
Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
- Mar 27th, 2023 12:00 pm
Scroll